June 28, 2005 — The European Commission has approved a resorbable bone graft substitute plus synthetic growth factor combination product for use in the permanent repair of bone defects caused by ...
Bank One ONE disclosed that it expects regulators to take enforcement action against the bank's mutual fund adviser. Shares of Bank One, which shed 30 cents to end the regular session at $43.15, rose ...
Jan. 18, 2006 — The European Commission has approved a molecular blood test for use as an aid in the detection and diagnosis of lung cancer, and an accommodative intraocular lens for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results